<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Jellen LC</submitter><funding>Michael J. Fox Foundation for Parkinson's Research</funding><funding>Michael J. Fox Foundation for Parkinson&amp;apos;s Research</funding><pagination>116</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12056004</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>11(1)</volume><pubmed_abstract>We previously demonstrated that kynurenine pathway (KP) dysregulation associates with Parkinson's disease (PD) and its symptoms. Here, we profiled 16 KP-related markers in a second, independent cohort; plasma: n = 202 (116 PD ("OFF"), 86 controls); CSF: n = 183 (108, 75). Consistent with previous findings, we detected significantly higher concentrations of neurotoxic 3-hydroxykynurenine in plasma and lower concentrations of neuroprotective kynurenic acid along with higher neurotoxic quinolinic acid/kynurenic acid ratios in CSF of PD patients. Additionally, 10 markers showed sex-based differences, with more pronounced dysregulation in females. These 10 markers loaded to a single principal component linked to higher UPDRS I and II scores. Together, this suggests a composite signature of KP d</pubmed_abstract><journal>NPJ Parkinson's disease</journal><pubmed_title>Sex differences in peripheral and central dysregulation of the kynurenine pathway in Parkinson's disease.</pubmed_title><pmcid>PMC12056004</pmcid><funding_grant_id>MJFF-010296</funding_grant_id><pubmed_authors>Kong L</pubmed_authors><pubmed_authors>Lewis MM</pubmed_authors><pubmed_authors>Madaj Z</pubmed_authors><pubmed_authors>Huang X</pubmed_authors><pubmed_authors>Brundin L</pubmed_authors><pubmed_authors>Johnson A</pubmed_authors><pubmed_authors>Isaguirre C</pubmed_authors><pubmed_authors>Sheldon RD</pubmed_authors><pubmed_authors>Escobar Galvis ML</pubmed_authors><pubmed_authors>Jellen LC</pubmed_authors><pubmed_authors>Sha Q</pubmed_authors></additional><is_claimable>false</is_claimable><name>Sex differences in peripheral and central dysregulation of the kynurenine pathway in Parkinson's disease.</name><description>We previously demonstrated that kynurenine pathway (KP) dysregulation associates with Parkinson's disease (PD) and its symptoms. Here, we profiled 16 KP-related markers in a second, independent cohort; plasma: n = 202 (116 PD ("OFF"), 86 controls); CSF: n = 183 (108, 75). Consistent with previous findings, we detected significantly higher concentrations of neurotoxic 3-hydroxykynurenine in plasma and lower concentrations of neuroprotective kynurenic acid along with higher neurotoxic quinolinic acid/kynurenic acid ratios in CSF of PD patients. Additionally, 10 markers showed sex-based differences, with more pronounced dysregulation in females. These 10 markers loaded to a single principal component linked to higher UPDRS I and II scores. Together, this suggests a composite signature of KP d</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 May</publication><modification>2026-06-01T19:17:49.39Z</modification><creation>2026-05-21T03:09:04.75Z</creation></dates><accession>S-EPMC12056004</accession><cross_references><pubmed>40328760</pubmed><doi>10.1038/s41531-025-00949-6</doi></cross_references></HashMap>